TPST

Tempest Therpeutics (TPST)

Tempest Therpeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:TPST

1 2 3 4 5 6 7 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/21	21:00	GlobeNewswire Inc.	Tempest to Participate in Upcoming Investor Conferences	NASDAQ:TPST	Tempest Therpeutics Inc
2024/05/14	05:54	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:TPST	Tempest Therpeutics Inc
2024/05/10	05:29	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:TPST	Tempest Therpeutics Inc
2024/05/10	05:29	GlobeNewswire Inc.	Tempest Reports First Quarter 2024 Financial Results and Provides Business Update	NASDAQ:TPST	Tempest Therpeutics Inc
2024/05/10	05:25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TPST	Tempest Therpeutics Inc
2024/04/27	05:05	GlobeNewswire Inc.	Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:TPST	Tempest Therpeutics Inc
2024/04/09	21:00	GlobeNewswire Inc.	Tempest Reports New Preclinical Data for TPST-1120 in RCC at the AACR Annual Meeting	NASDAQ:TPST	Tempest Therpeutics Inc
2024/04/04	21:00	GlobeNewswire Inc.	Tempest Announces Publication of Positive Data from Phase 1 Trial of TPST-1120 in Patients with Advanced Solid Tumors in Journal of Cancer Research Communications	NASDAQ:TPST	Tempest Therpeutics Inc
2024/03/20	05:25	GlobeNewswire Inc.	Tempest Reports Year End 2023 Financial Results and Provides Business Update	NASDAQ:TPST	Tempest Therpeutics Inc
2024/03/12	21:00	GlobeNewswire Inc.	Tempest Presents New Data at the SITC 2024 Spring Scientific Meeting Supporting Potent Anti-tumor Activity of TPST-1120 in Multiple Cancer Types	NASDAQ:TPST	Tempest Therpeutics Inc
2024/03/06	06:30	GlobeNewswire Inc.	Tempest Announces Upcoming Presentation of Preclinical Data for TPST-1120 in Renal Cell Carcinoma at the AACR Annual Meeting	NASDAQ:TPST	Tempest Therpeutics Inc
2024/02/26	22:00	GlobeNewswire Inc.	Tempest to Present at the 44th Annual TD Cowen Healthcare Conference	NASDAQ:TPST	Tempest Therpeutics Inc
2024/02/15	08:49	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:TPST	Tempest Therpeutics Inc
2024/02/15	04:12	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:TPST	Tempest Therpeutics Inc
2024/02/09	07:41	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:TPST	Tempest Therpeutics Inc
2024/02/03	06:30	GlobeNewswire Inc.	Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:TPST	Tempest Therpeutics Inc
2024/01/06	06:41	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TPST	Tempest Therpeutics Inc
2024/01/06	06:40	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TPST	Tempest Therpeutics Inc
2024/01/06	06:39	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TPST	Tempest Therpeutics Inc
2024/01/06	06:38	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TPST	Tempest Therpeutics Inc
2024/01/06	06:05	GlobeNewswire Inc.	Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:TPST	Tempest Therpeutics Inc
2023/12/02	06:15	GlobeNewswire Inc.	Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:TPST	Tempest Therpeutics Inc
2023/11/20	22:00	GlobeNewswire Inc.	Tempest to Present at the 35th Annual Piper Sandler Healthcare Conference	NASDAQ:TPST	Tempest Therpeutics Inc
2023/11/18	06:46	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:TPST	Tempest Therpeutics Inc
2023/11/18	06:45	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:TPST	Tempest Therpeutics Inc
2023/11/18	06:44	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:TPST	Tempest Therpeutics Inc
2023/11/18	06:44	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:TPST	Tempest Therpeutics Inc
2023/11/18	06:43	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:TPST	Tempest Therpeutics Inc
2023/11/18	06:39	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:TPST	Tempest Therpeutics Inc
2023/11/10	07:28	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:TPST	Tempest Therpeutics Inc